widely accepted theory alzheimer destroys memory cell body produces beta amyloid brain not clear fast starts clump gumming synapses amassing neuron killing plaques antiamyloid monoclonal antibodies designed bind fragments flag removal immune system meeting pharmaceutical company biogen presented new findings ongoing study monoclonal candidate aducanumab biogen announced fanfare march drug significantly reduced beta amyloid plaques seen pet scans slowed cognitive impairment 166 patients mild alzheimer patients dose tested--10 milligrams kilogram body weight maintained highest memory scores experienced localized brain swelling effect linked leaky blood vessels midtrial introduced hoped goldilocks dose not not little not right biogen researchers revealed milligrams produced